CIK 0001761918 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Erasca, Inc.
Sign in to watch- Ticker
- ERAS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 831217027
- Phone
- (858) 465-6511
- Business address
- 3115 MERRYFIELD ROW, THIRD FLOOR, SAN DIEGO, CA, 92121
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 10 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-06-14 | Garner Ebun General Counsel & Corp. Sec. | Other acquisition | +5,715 | $1.56 | $9K | 21,174 |
| 2024-05-21 | Casdin Alexander W. Director | Purchase | +80,000 | $2.27 | $182K | 573,974 |
| 2024-02-05 | Lim Jonathan E Chairman & CEO | Grant or award · Stock Option (right to buy) | +1,500,000 | 1,500,000 | ||
| 2024-02-05 | Chacko David M. CFO and CBO | Grant or award · Stock Option (right to buy) | +600,000 | 600,000 | ||
| 2024-02-05 | Garner Ebun General Counsel & Corp. Sec. | Grant or award · Stock Option (right to buy) | +480,000 | 480,000 | ||
| 2024-02-05 | Morris Shannon Chief Medical Officer | Grant or award · Stock Option (right to buy) | +535,800 | 535,800 | ||
| 2024-01-01 | Bristol James Arthur Director | Grant or award · Stock Option (right to buy) | +62,747 | 62,747 | ||
| 2024-01-01 | Multani Pratik S Director | Grant or award · Stock Option (right to buy) | +32,867 | 32,867 | ||
| 2024-01-01 | LIU JEAN I Director | Grant or award · Stock Option (right to buy) | +35,482 | 35,482 | ||
| 2024-01-01 | Start Valerie Denise Harding Director | Grant or award · Stock Option (right to buy) | +39,590 | 39,590 | ||
| 2024-01-01 | Casdin Alexander W. Director | Grant or award · Stock Option (right to buy) | +41,084 | 41,084 | ||
| 2023-12-15 | Chacko David M. CFO and CBO | Other acquisition | +7,478 | $1.59 | $12K | 246,726 |
| 2023-12-15 | Garner Ebun General Counsel & Corp. Sec. | Other acquisition | +5,448 | $1.59 | $9K | 9,728 |
| 2023-12-06 | Start Valerie Denise Harding Director | Purchase | +10,000 | $1.85 | $18K | 20,000 |
| 2023-12-06 | Lim Jonathan E Chairman & CEO | Purchase | +278,150 | $1.72 | $478K | 12,899,360 |
| 2023-12-05 | Lim Jonathan E Chairman & CEO | Purchase | +721,850 | $1.69 | $1.2M | 12,899,360 |
| 2023-12-04 | Casdin Alexander W. Director | Purchase | +30,000 | $1.66 | $50K | 493,974 |
| 2023-10-05 | Lim Jonathan E Chairman & CEO | Purchase | +1,000,000 | $2.03 | $2.0M | 19,456,216 |
| 2023-06-22 | Varney Michael David Director | Grant or award · Stock Option (right to buy) | +60,000 | 60,000 | ||
| 2023-06-22 | Multani Pratik S Director | Grant or award · Stock Option (right to buy) | +60,000 | 60,000 |
Page 4 of 7 · 121 trades